packageRozanolixizumab

rozanolixizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rozanolixizumab is a monoclonal antibody used to treat myasthenia gravis. It is an authorised medicine in the European Union, given as an immunosuppressant that blocks the neonatal Fc receptor.

Summary written by glm-5.3-flash from Wikidata Q120491843 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rozanolixizumab
ATC codes:L04AG16, L04AL02
DrugBank:DB14919
Wikidata:Q120491843
molar mass:148000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown